FDA Provides Guidance on DCT Elements, Multiregional Trials and Integrating Randomized Trials into Clinical Practice
September 17, 2024 at 03:18 PM EST
The FDA released three guidances with implications for clinical trials. The release included final guidance on conducting clinical trials with decentralized elements and a draft guidance on integrating randomized controlled trials for drug and biological products into routine clinical practice on Sept. 17 and a draft guidance on generating clinical evidence from oncology multi... Read More
